Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vascugel in Arteriovenous Graft Surgery
NCT01806584Phase 2Terminated
- Sponsor
- Takeda
- Start
- Mar 2013
- Primary completion
- Oct 2014
- Modality
- Hydrogel Systems, Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of Vascugel in vascular injury, sponsored by Takeda. Started Mar 2013; status: terminated.
02
Drugs
Vascugel
03
Conditions
vascular injury
Beyond the preview
Go deeper on NCT01806584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01806584.